suramin has been researched along with u 0126 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGovern, SL; Shoichet, BK | 1 |
| Bergström, JD; Heldin, NE; Westermark, B | 1 |
| Holbrook, NJ; Martindale, JL; Wang, X | 1 |
| Joshi, PG; Lakshmi, S | 1 |
| Ren, Y; Wang, W; Xie, Q; Yi, X | 1 |
5 other study(ies) available for suramin and u 0126
| Article | Year |
|---|---|
Kinase inhibitors: not just for kinases anymore.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Biological; Phosphotransferases; Scattering, Radiation | 2003 |
Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells.
Topics: Antineoplastic Agents; Butadienes; Carcinoma; Enzyme Inhibitors; ErbB Receptors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Nitriles; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-met; Quinazolines; RNA, Messenger; Suramin; Thyroid Neoplasms; Transforming Growth Factor alpha; Tumor Cells, Cultured; Tyrphostins | 2000 |
Requirement for ERK activation in cisplatin-induced apoptosis.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Blotting, Western; Butadienes; Caspase 3; Caspases; Cell Line; Cell Survival; Cisplatin; Cysteine Proteinase Inhibitors; Cytochrome c Group; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; HeLa Cells; Humans; Indoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Models, Biological; Nitriles; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Signal Transduction; Suramin; Tetradecanoylphorbol Acetate; Time Factors | 2000 |
Activation of Src/kinase/phospholipase C/mitogen-activated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor.
Topics: Adenosine; Adenosine Triphosphate; Animals; Butadienes; Cell Line, Tumor; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Mice; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neurites; Neuroblastoma; Nitriles; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; src-Family Kinases; Suramin; Type C Phospholipases | 2006 |
Effects of Adenosine Triphosphate on Proliferation and Odontoblastic Differentiation of Human Dental Pulp Cells.
Topics: Adenosine Triphosphate; Adult; Butadienes; Cell Cycle; Cell Differentiation; Cell Line; Cell Proliferation; Dental Pulp; Dentinogenesis; Female; Humans; Male; Nitriles; Odontoblasts; Receptors, Purinergic P2; RNA, Messenger; Suramin; Young Adult | 2016 |